Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Nov 17, 2025
- Accession no.
- 0001193125-25-284935
- Filed
- Nov 17, 2025
- Trade date
- Nov 13-17, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.11M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,111 | $16.00 | −$17,776 | 426,870 | Direct | |
| Nov 14, 2025 | Common Stock | SSaleDisposed | −110,228 | $16.02 | −$1,765,852.56 | 316,642 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −18,572 | $16.11 | −$299,194.92 | 298,070 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −1,500 | $17.07 | −$25,605 | 296,570 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.